$1.44
0.07[5.11%]
At close: Apr 17
$1.44
0[0.00%]
PreMarket: 8:15AM EDT
Latest News for Exagen Stock (NASDAQ:XGN)
Exagen Stock (NASDAQ: XGN)
Categories: All
Monday, March 18, 2024
- Exagen shares are trading higher after the company reported better than expected Q4 FY2023 earnings and issued FY2024 guidance.Benzinga Newsdesk - Mar 18, 2024, 8:14AM
- Exagen Expects Q1 FY2024 Revenue Of $13M-$13.5M Versus Consensus Of $11.49M, The Company Says Existing Cash And Cash Equivalents Of $36.5M Will Be Adequate To Meet Anticipated Cash Requirements Into 2026Benzinga Newsdesk - Mar 18, 2024, 8:09AM
- Exagen Expects FY2024 Revenue Of Approximately $54M Versus Consensus Of $54.14M; For FY2024, the Company Expects Adjusted EBITDA Will Be Better Than Negative $20MBenzinga Newsdesk - Mar 18, 2024, 8:07AM
- Exagen Q4 GAAP EPS $(0.31) Beats $(0.43) Estimate, Sales $13.77M Beat $11.56M EstimateBenzinga Newsdesk - Mar 18, 2024, 8:03AM
- Earnings Scheduled For March 18, 2024Benzinga Insights - Mar 18, 2024, 5:57AM
Friday, March 15, 2024
Sunday, January 07, 2024
Friday, January 05, 2024
Thursday, January 04, 2024
Friday, December 01, 2023
Tuesday, November 21, 2023
Monday, November 20, 2023
Friday, November 17, 2023
- Exagen Inc Entered Into Amendment No. 1 To That Certain Sales Agreement, Dated September 15, 2022; May, From Time To Time, Continue To Issue, Sell Shares Of Common Stock, Having An Aggregate Offering Price Of Up To $50MBenzinga Newsdesk - Nov 17, 2023, 4:38PM
- Exagen Inc Files For Mixed Shelf Of Up To $150MBenzinga Newsdesk - Nov 17, 2023, 4:12PM
Wednesday, November 15, 2023
Tuesday, November 14, 2023
Monday, November 13, 2023
- Exagen Inc. Says FY23 Revenue Guidance Of At Least $50M Vs $46.76M Est.Benzinga Newsdesk - Nov 13, 2023, 4:51PM
- Exagen Q3 2023 Gaap EPS $(0.31) Beats $(0.46) Estimate, Sales $13.42M Beat $10.33M EstimateBenzinga Newsdesk - Nov 13, 2023, 4:15PM
- Earnings Scheduled For November 13, 2023Benzinga Insights - Nov 13, 2023, 6:40AM
Friday, November 10, 2023
Thursday, November 09, 2023
Tuesday, November 07, 2023
Tuesday, October 17, 2023
Friday, October 06, 2023
Thursday, October 05, 2023
Tuesday, September 26, 2023
Tuesday, September 19, 2023
Tuesday, August 22, 2023
Monday, August 07, 2023
- Exagen Expects 3Q23 Revenue Of $10M-$10.5M Vs. Consensus Of $11.76MBenzinga Newsdesk - Aug 7, 2023, 8:06AM
- Exagen Q2 EPS $(0.28) Beats $(0.48) Estimate, Sales $14.14M Beat $10.97M EstimateBenzinga Newsdesk - Aug 7, 2023, 8:02AM
- Earnings Scheduled For August 7, 2023Benzinga Insights - Aug 7, 2023, 4:12AM
Friday, August 04, 2023
Thursday, July 27, 2023
Tuesday, May 16, 2023
Monday, May 15, 2023
Wednesday, March 22, 2023
Tuesday, March 21, 2023
Monday, March 20, 2023
- Exagen Raises Q1 Revenue Guidance From $8.2M-$9.2M To $9.2M-$9.7M Vs $9.33M EstHappy Mohamed - Mar 20, 2023, 4:07PM
- Exagen Q4 EPS $(0.83) Misses $(0.78) Estimate, Sales $12.84M Beat $8.66M EstimateHappy Mohamed - Mar 20, 2023, 4:05PM
- Earnings Scheduled For March 20, 2023Benzinga Insights - Mar 20, 2023, 5:27AM